Perspective · 10 Sep 2026
Research articlePublished 2015
Deficiency of Mannose Associated Serine Protease2 (MASP2) in Patients with Idiopathic Pulmonary Fibrosis
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Idiopathic pulmonary fibrosis (UIP/IPF) is increasing. The condition occurs both sporadically and in close blood relatives suggesting a genetic predisposition. Histology suggests that the fibrosis is linked to disordered apoptosis, but the causal agent is so far unrecognised. We previously published evidence of mannose binding lectin deficiency (MBL) in early onset disease and in those with a family history of UIP/IPF. MBL is part of the innate immune system with levels genetically determined. MBL activation is impaired if the mannose associated serine protease2 (MASP2) is severely deficient in the serum (levels 100 ng/ml) showed no differences between Healthy Controls, COPD, TB and sarcoid. UIP/IPF showed a significant increase in the frequency of severe deficiency. This was seen for early onset disease 55yrs (20% p=0.0001) and those with a family history (19% p=0.0143). The expected frequency for the Caucasian population is <1%. Conclusion: The data shows that severe MASP2 deficiency is seen in our UIP/IPF patients and is highest in those with early onset disease. For TB and Sarcoid there is an increased frequency of deficiency (67%) compared with healthy controls (3%): and these diseases can also give fibrotic scarring to the lung. Since MASP2 levels<100 ng/ml are considered to cause impaired function of the lectin pathway it could have relevance to complement activation, apoptosis and fibrosis in this disease.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Longdom does not store it.
More from this journal
The newest in Journal of Clinical and Cellular Immunology.
Commentary · 22 Jul 2026
From Bench to Bedside: Reframing the CXCL13/CXCR5 Axis as a Non-Redundant Organizer of Protective Pulmonary Immunity in COVID-19
Commentary · 17 Jul 2026
CD5L:p40, a third wheel to IL-12 and IL-23 biology?
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Cellular Immunology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Varney VA”
- BylineArticles whose byline prints “Parnell H”
- BylineArticles whose byline prints “Quirke G”
- BylineArticles whose byline prints “Bansal A”
- BylineArticles whose byline prints “Sumar N”
- BylineArticles whose byline prints “Nicholas A”
- BylineArticles whose byline prints “Evans J”
